Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Thursday - 14 May 2026

Thursday, 14 May 2026

Questions (521)

Brian Stanley

Question:

521. Deputy Brian Stanley asked the Minister for Health if her Department has assessed the impact on patients, particularly those with neurological, developmental, or sleep-related conditions, of melatonin and magnesium not being covered under the long-term illness scheme; and if she will make a statement on the matter. [35831/26]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Share